NCT02558387 2015-11-20Trial of BIBF1120 (Nintedanib) in Patients With Recurrent or Metastatic Salivary Gland Cancer of the Head and NeckSamsung Medical CenterPhase 2 Unknown20 enrolled
NCT02278978 2015-05-12BIBF1120 in Patients With Advanced FGFR3 Mutated,Overexpressed,or Wild Type Urothelial CarcinomaNational Taiwan University HospitalPhase 2 Unknown129 enrolled